The group is made up of specialists in molecular imaging, chemical and pharmaceutical specialists in the synthesis of tracers, and biomedical and physical engineers specialised in imaging treatment and tomography equipment.

With this multidisciplinary team, and on the basis of medical imaging, the group works on three different lines of research. On the one hand, it focuses on identifying new markets and tracers, in direct relation to clinical trials. A second line is dedicated to the different aspects of medical imaging, from nuclear medicine and radiology, such as the capture, clinical and preclinical assessment and evaluation of medical images. A final line is dedicated to researching different pathologies based on the use of images acquired using different techniques, to later be studied and processed, with the help of image processing tools and specific statistical software. Due to the nature of its projects, the group works interdepartmentally in collaboration with other campus teams. 

Visit the research group’s page

 

Ponderació
9

Subscribe to our newsletters and be a part of Campus Life

Select the newsletter you want to receive:

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vhebron.net, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.